EXPECTANT MANAGEMENT ON PRETERM PREGNANCY WITH PREECLAMPSIA: A SCOPING REVIEW

Putu Ayu Dina Saraswati, Dwi Ernawati, Mufdlilah

Abstract


Preeclampsia complicates 5-8% of all pregnancies and is responsible for 100 maternal deaths and 400 perinatal deaths every day globally. In the worldwide, preeclampsia and eclampsia are considered as the factors for approximately 14% of maternal deaths and prematurity, in the 30-34 week gestation period. Yet, they are remained to be associated with high perinatal mortality rates in Indonesia (28% perinatal mortality). The aim of this study was to conduct a scoping review to determine the effectiveness of expectant management for less-month pregnancies with preeclampsia. There were five stages for the scoping review. The five stages include: identifying research questions, identifying relevant literature, selecting literature, mapping data, compiling, summarizing and reporting results. All selected articles were taken using quantitative method. From 12 journals gathered, thematic analysis was carried out to identify the main points. We classify the main points of expectant management as an effort to prolong pregnancy, as expectant management with the time of termination of pregnancy, and as expectant management with the right gestational age. The average length of pregnancy in women with preeclampsia without any other risk is 11.5 days. Clinical decisions for termination of pregnancy or expectant management are highly depended on the mother, fetus and laboratory. The experience of the obstetricians also influences the decision to terminate the pregnancy during the maternal evaluation.

Keywords: preterm, pregnancy, preeclampsia, management


Full Text:

PDF

Article Metrics

Abstract view : 24
PDF - 8

References


Muhani, Nova et al. 2014. “884-1914-1-Pb.” (27).

Ueda, Akihiko et al. 2016. “Magnesium Sulphate Can Prolong Pregnancy in Patients with Severe Early-Onset Preeclampsia.” Journal of Maternal-Fetal and Neonatal Medicine 29(19):3115–20.

Mooney, Samantha S., Rilka M. Lee, Stephen Tong, and Fiona C. Brownfoot. 2016. “Expectant Management of Severe Preterm Preeclampsia: A Comparison of Maternal and Fetal Indications for Delivery.” Journal of Maternal-Fetal and Neonatal Medicine 29(23):3821–26.

Valent, Amy M. et al. 2015. “Expectant Management of Mild Preeclampsia versus Superimposed Preeclampsia up to 37 Weeks.” American Journal of Obstetrics and Gynecology 212(4):515.e1-515.e8.

Chen, Q., F. Shen, Y. F. Gao, and M. Zhao. 2015. “An Analysis of Expectant Management in Women with Early-Onset Preeclampsia in China.” Journal of Human Hypertension 29(6):379–84.

Ernawati, Erry Gumilar, Kuntoro, Joewono Soeroso, and Gus Dekker. 2016. “Expectant Management of Preterm Preeclampsia in Indonesia and the Role of Steroids.” Journal of Maternal-Fetal and Neonatal Medicine 29(11):1736–40.

Suzuki, Shunji, Manabu Shimada, and Yoshie Shibata-Hiraizumi. 2014. “Clinical Trial of Expectant Management of Severe Preeclampsia That Develops at <32 Weeks‟ Gestation at a

Japanese Perinatal Center.” Journal of Maternal-Fetal and Neonatal Medicine 27(15):1568–71.

Valent, Amy M. et al. 2015. “Expectant Management of Mild Preeclampsia versus Superimposed Preeclampsia up to 37 Weeks.” American Journal of Obstetrics and Gynecology 212(4):515.e1-515.e8.

McKinney, David et al. 2016. “The Impact of Fetal Growth Restriction on Latency in the Setting of Expectant Management of Preeclampsia.” American Journal of Obstetrics and Gynecology 214(3):395.e1-395.e7.

Aoki, Shigeru et al. 2014. “Expectant Management of Severe Preeclampsia with Severe Fetal Growth Restriction in the Second Trimester.” Pregnancy Hypertension 4(1):81–86.

Vigil-De Gracia, Paulino et al. 2014. “Expectant Management of Severe Preeclampsia Remote from Term: The MEXPRE Latin Study, a Randomized, Multicenter Clinical Trial.” Obstetrical and Gynecological Survey 69(3):133–34.

Belghiti, Jérémi et al. 2011. “Benefits and Risks of Expectant Management of Severe Preeclampsia at Less than 26 Weeks Gestation: The Impact of Gestational Age and Severe Fetal Growth Restriction.” American Journal of Obstetrics and Gynecology 205(5):465.e1-465.e6.

Bombrys, Annette E. et al. 2008. “Expectant Management of Severe Preeclampsia at Less than 27 Weeks‟ Gestation: Maternal and Perinatal Outcomes According to Gestational Age by Weeks at Onset of Expectant Management.” American Journal of Obstetrics and Gynecology 199(3):1–6.

Johnston, R. C. et al. 2016. “Assessing Progression from Mild to Severe Preeclampsia in Expectantly Managed Preterm Parturients.” Pregnancy Hypertension 6(4):340–43.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Proceeding International Conference